Kuros Biosciences AG
CSBTFOTCHealthcare● Active
$26.00
+$1.25(+5.05%)
Market Cap$1.0B
P/E Ratio—
52W High$42.81
52W Low$24.75
Kuros Biosciences AG (CSBTF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CSBTF · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2026Report Date: Mar 10, 2026EPS Actual
$0.12
Revenue
$0.08B
Est. $0.08B · -2.5%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Mar 10, 2026
After Market Close
▼ Miss Revenue✓ 1-Quarter EPS Beat Streak
CSBTF reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 13, 2026 | — | — | — | — | $0.09B | — |
| — Q1 FY2026 | Mar 10, 2026 | — | $0.12 | — | $0.08B | $0.08B | -2.5% |
| — Q3 FY2025 | Aug 14, 2025 | — | -$0.06 | — | $0.08B | $0.06B | +32.0% |
| — Q1 FY2025 | Mar 11, 2025 | — | -$0.10 | — | $0.05B | $0.05B | -3.5% |
| — Q4 FY2024 | Oct 10, 2024 | — | -$0.01 | — | $0.04B | $0.03B | +6.5% |
| — Q1 FY2024 | Mar 13, 2024 | — | -$0.28 | — | $0.02B | $0.02B | +8.9% |
| — Q2 FY2023 | Jun 30, 2023 | — | -$0.15 | — | $0.01B | $0.01B | +36.6% |
| — Q4 FY2022 | Dec 31, 2022 | — | -$0.34 | — | $0.01B | $0.01B | -14.1% |
Q3 FY2026
Aug 13, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 10, 2026
EPS Actual
$0.12
EPS Est.
—
EPS Surpr.
—
Revenue
$0.08B
Q3 FY2025
Aug 14, 2025
EPS Actual
-$0.06
EPS Est.
—
EPS Surpr.
—
Revenue
$0.08B
Q1 FY2025
Mar 11, 2025
EPS Actual
-$0.10
EPS Est.
—
EPS Surpr.
—
Revenue
$0.05B
Q4 FY2024
Oct 10, 2024
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.04B
Q1 FY2024
Mar 13, 2024
EPS Actual
-$0.28
EPS Est.
—
EPS Surpr.
—
Revenue
$0.02B
Q2 FY2023
Jun 30, 2023
EPS Actual
-$0.15
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q4 FY2022
Dec 31, 2022
EPS Actual
-$0.34
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2024 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2024 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.1B | $0.1B | $0.1B | 1 |
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2026 | Mar 10, 2026 | — | $33.40 | $36.78 | +10.12% |
| — Q3 FY2025 | Aug 14, 2025 | — | $35.84 | $34.75 | -3.04% |
| — Q1 FY2025 | Mar 11, 2025 | — | $23.35 | $22.60 | -3.21% |
| — Q4 FY2024 | Oct 10, 2024 | — | $22.00 | $22.00 | +0.00% |
| — Q1 FY2024 | Mar 13, 2024 | — | $6.30 | $6.00 | -4.76% |
| — Q2 FY2023 | Jun 30, 2023 | — | $1.89 | $1.89 | +0.00% |
| — Q4 FY2022 | Dec 31, 2022 | — | $1.92 | $1.92 | +0.00% |
| — Q2 FY2022 | Jun 30, 2022 | — | $1.92 | $1.92 | +0.00% |
Q1 FY2026+10.12%
Report Date
Mar 10, 2026
EPS Beat/Miss
—
Price Before
$33.40
Price After
$36.78
Q3 FY2025-3.04%
Report Date
Aug 14, 2025
EPS Beat/Miss
—
Price Before
$35.84
Price After
$34.75
Q1 FY2025-3.21%
Report Date
Mar 11, 2025
EPS Beat/Miss
—
Price Before
$23.35
Price After
$22.60
Q4 FY2024+0.00%
Report Date
Oct 10, 2024
EPS Beat/Miss
—
Price Before
$22.00
Price After
$22.00
Q1 FY2024-4.76%
Report Date
Mar 13, 2024
EPS Beat/Miss
—
Price Before
$6.30
Price After
$6.00
Q2 FY2023+0.00%
Report Date
Jun 30, 2023
EPS Beat/Miss
—
Price Before
$1.89
Price After
$1.89
Q4 FY2022+0.00%
Report Date
Dec 31, 2022
EPS Beat/Miss
—
Price Before
$1.92
Price After
$1.92
Q2 FY2022+0.00%
Report Date
Jun 30, 2022
EPS Beat/Miss
—
Price Before
$1.92
Price After
$1.92
Beat Rate0 / 8 quarters
Largest Move+10.12% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CSBTF ends December
Kuros Biosciences AG (CSBTF) most recently reported earnings on March 10, 2026 for Q1 FY2026, posting EPS of $0.12 (in line with the analyst consensus of —). The next CSBTF earnings date is expected around September 1, 2026.
Each quarter, investors track CSBTF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CSBTF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CSBTF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CSBTF earnings · 4 questionsKuros Biosciences AG's next earnings report is expected around September 1, 2026. CSBTF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CSBTF historically reports after market close (AMC).
CSBTF earnings datewhen is CSBTF earningsCSBTF next earnings datewhen does CSBTF report earningsCSBTF earnings calendar
▸ Source: FMP · Kuros Biosciences AG SEC filings · US GAAP · Kuros Biosciences AG SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026